Top cited articles

Autopsy in suspected COVID-19 cases
Hanley, Brian; Lucas, Sebastian B.; Youd, Esther; Swift, Benjamin; Osborn, Michael
10.1136/jclinpath-2020-206522

Testing algorithm for identification of patients with TRK fusion cancer
Penault-Llorca, Frederique; Rudzinski, Erin R.; Sepulveda, Antonia R.
10.1136/jclinpath-2018-205679

Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein
Pillay, Tahir S.
10.1136/jclinpath-2020-206658

COVID-19 autopsy in people who died in community settings: the first series
Youd, Esther; Moore, Luiza
10.1136/jclinpath-2020-206710

Molecular pathology of neurodegenerative diseases: principles and practice
Kovacs, Gabor G.
10.1136/jclinpath-2019-205952

Towards effective diagnostic assays for COVID-19: a review
Venter, Marietjie; Richter, Karin
10.1136/jclinpath-2020-206685

TERT gene: its function and dysregulation in cancer
Colebatch, Andrew J.; Dobrovic, Alexander; Cooper, Wendy A.
10.1136/jclinpath-2018-205653

Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer
D’Elia, Carolina; Pycha, Alexander; Folchini, Decio M.; Mian, Christine; Hanspeter, Esther et al
10.1136/jclinpath-2018-205393

Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours
Linder, Nina; Taylor, Jenny C.; Colling, Richard; Pell, Robert; Alveyn, Edward et al
10.1136/jclinpath-2018-205328

Circular PVT1: an oncogenic non-coding RNA with emerging clinical importance
Adhikary, Jayashree; Chakraborty, Sourabrata; Dalal, Subhamita; Basu, Souradip; Dey, Abhijit; Ghosh, Amlan
10.1136/jclinpath-2019-205891

Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC
Yeong, Joe; Tan, Tira; Chow, Zi Long. et al
10.1136/jclinpath-2019-206252

International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome
Hodgson, Anjelica; Olkhov-Mitsel, Ekaterina; Howitt, Brooke E.; Nucci, Marisa R.; Parra-Herran, Carlos
10.1136/jclinpath-2018-205632

Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
Kerr, Jonathan R.
10.1136/jclinpath-2019-205822

High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Jin, Qin; Dai, Yanfeng; Wang, Yan; Zhang, Shu; Liu, Gang
10.1136/jclinpath-2018-205390

SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma
Guerini-Rocco, Elena; Taormina, Sergio Vincenzo; Vacirca, Davide. et al
10.1136/jclinpath-2020-206635

Neurotrophic tropomyosin or tyrosine receptor kinase (NTRK) genes
Chetty, Runjan
10.1136/jclinpath-2018-205672

Molecular point-of-care testing for influenza A/B and respiratory syncytial virus: comparison of workflow parameters for the ID Now and cobas Liat systems
Young, Stephen; Phillips, Jamie; Griego-Fullbright, Christen et al
10.1136/jclinpath-2019-206242

Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19
Stadlmann, Sylvia; Hein-Kuhnt, Robert; Singer, Gad
10.1136/jclinpath-2020-206657

Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing
Van Haele, Matthias; Vander Borght, Sara; Ceulemans. et al
10.1136/jclinpath-2019-205970

Implementing a structured digital-based online pathology curriculum for trainees at the time of COVID-19
Roy, Simon F.; Cecchini, Matthew J.
10.1136/jclinpath-2020-206682